Support for Vaccine Development Deadline: Friday 6 May 2016 5:00 p.m. CET The High Impact project on Advanced Immunization Technologies (ADITEC), funded through the 7th Framework Programme of the European Union, aims to accelerate the development of novel and powerful […]
Support for Vaccine Development Deadline: 30 October 2015 5:00 p.m. CET Anticipated Decision Date 30 November 2015 The High Impact project on Advanced Immunization Technologies (ADITEC), funded through the 7th Framework Programme of the European Union, aims to accelerate the […]
Support for Vaccine Development Deadline: 30 Jan 2015 5:00 p.m. CET Anticipated Decision Date 8 April 2015 The High Impact project on Advanced Immunization Technologies (ADITEC), funded through the 7th Framework Programme of the European Union, aims to accelerate the […]
Partners of the ADITEC consortium are presenting the third course on adjuvants and vaccine formulation. Dates: 9-13 February 2015 Location: Vaccine Formulation Laboratory at University of Lausanne, Switzerland Topics: Formulation and characterization of Aluminum salts, Water-in-Oil emulsions, Oil-in-Water emulsions, and […]
Support for Vaccine Development Deadline: 30 May 2014 5:00 p.m. CET Anticipated Decision Date 30 June 2014 Please forward this message to anyone who could be interested. The High Impact project on Advanced Immunization Technologies (ADITEC), funded through the 7th […]
Partners of the ADITEC consortium are presenting a module of two courses in adjuvants and vaccine formulation. The two courses will take place in September 2013 at the Vaccine Formulation Laboratory at the University of Lausanne, Switzerland. The theoretical course: […]
Support for Vaccine Development Deadline: 30 May 2013 5:00 p.m. CEST Anticipated Decision Date 30 June 2013 Please forward this message to anyone who could be interested. The High Impact project on Advanced Immunization Technologies (ADITEC), funded through the 7th […]
The Bill & Melinda Gates Foundation’s TB Vaccine Accelerator Program is requesting applications for projects that will help meet one or both of the following two interrelated goals: To develop novel approaches to vaccination against Mycobacterium tuberculosis (Mtb), with a […]
ADITEC partner TBVI has opened a call for proposals for early clinical development of new, promising TB vaccines. This call focuses on support for cGMP manufacturing, toxicity and safety evaluation of new promising vaccine candidates, and/or support for carrying out […]